因斯蒂尔生物公司 - 资产负债表 (Quarterly)

因斯蒂尔生物公司

资产负债表 (Quarterly)

因斯蒂尔生物公司资产负债表显示公司在某个时间点的帐户余额。资产负债表数据包括资产、流动资产、固定资产、不动产、厂房和设备、存货、无形资产、负债、流动负债、债务、资本租赁义务、普通股、留存收益、库存股和股东权益。

除每股单位外,所有数字都是 1,000,000.00。

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
现金 242 610 567 20 38 61 42 41 44 27 22 9 9 5 7 7 9 15 8
改变 (%) 152.22 -7.04 -96.40 84.26 63.54 -30.92 -3.17 6.32 -37.44 -20.42 -58.04 0.68 -40.36 23.65 -1.74 32.15 74.51 -49.97
流动资产 246 614 574 523 464 391 368 314 269 240 221 196 161 161 155 133 124 219 207
改变 (%) 149.36 -6.40 -8.94 -11.29 -15.80 -5.89 -14.69 -14.12 -10.86 -8.14 -11.31 -17.82 0.17 -3.79 -14.43 -6.11 76.16 -5.42
资产 319 696 673 647 610 565 569 533 482 427 408 340 326 306 294 273 264 237 231
改变 (%) 118.22 -3.37 -3.76 -5.78 -7.38 0.64 -6.30 -9.50 -11.40 -4.42 -16.66 -4.30 -5.94 -3.91 -7.39 -3.30 -9.91 -2.72
负债 27 31 37 46 55 56 110 122 119 116 112 106 100 100 99 96 94 93 99
改变 (%) 16.30 20.04 23.60 19.16 2.91 95.48 10.84 -2.97 -2.11 -3.64 -4.96 -6.07 0.68 -1.17 -3.09 -2.18 -1.69 7.33
公平 292 665 635 601 555 509 458 411 364 311 297 234 226 206 195 176 169 145 132
改变 (%) 127.51 -4.46 -5.36 -7.69 -8.40 -9.88 -10.42 -11.44 -14.43 -4.70 -21.08 -3.50 -8.86 -5.25 -9.58 -3.91 -14.47 -9.14
负债和股权 319 696 673 647 610 565 569 533 482 427 408 340 326 306 294 273 264 237 231
改变 (%) 118.22 -3.37 -3.76 -5.78 -7.38 0.64 -6.30 -9.50 -11.40 -4.42 -16.66 -4.30 -5.94 -3.91 -7.39 -3.30 -9.91 -2.72

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista